Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy

There is ample evidence that neoadjuvant chemotherapy of breast carcinoma is particularly efficient if the tumor presents signs of either a pre-existent or therapy-induced anticancer immune response. Antineoplastic chemotherapies are particularly beneficial if they succeed in inducing immunogenic ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoll, Gautier, Enot, David, Mlecnik, Bernhard, Galon, Jérôme, Zitvogel, Laurence, Kroemer, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004621/
https://www.ncbi.nlm.nih.gov/pubmed/24790795
http://dx.doi.org/10.4161/onci.27884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004621/
https://www.ncbi.nlm.nih.gov/pubmed/24790795
http://dx.doi.org/10.4161/onci.27884

Ejemplares similares